[1]
K. A. Schoedel, PhD, “Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users”, J of Opioid Management, vol. 8, no. 5, pp. 315–327, Sep. 2012.